I think some investors are getting ahead of events by talking about "total validation". The product is a long, long way from "total validation". It has been granted ODD, an important status but still only the first rung of a long and expensive ladder of trials and testing on humans. Getting a partnership is crucial and should result in a decent rise in the sp but the real rise will come with positive trial results.
If USA does attack Iran tonight we can expect markets worldwide to collapse. Couldn't have come at a worst time for us just as we are probably on the verge of a good partnership or investment in some form or another.